Icosavax Initiates Phase 1/1b Trial of VLP Vaccine Candidate Against Respiratory Syncytial Virus

NEXT STORY
Beroni Group Received Approval for 43.5% R&D Rebate from Australian Government for the Novel, Potential Anti-Cancer Drug PENAO
PREV STORY
Le Dr Benjamin Musher présidera l’étude de phase 1-2 évaluant le traitement anticancéreux Natrunix™ de XBiotech contre le cancer du pancréas
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Biomerica Launches New Website For Its EZ Detect™ Colorectal Disease Screening Test

author_avatar
NASDAQ Market News

Flexion Therapeutics Announces Publication of Results from Pivotal Phase 3 Study of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) in the Journal of Bone and Joint Surgery

author_avatar
NASDAQ Market News

NKGen Biotech Announces Acceptance of SNK01 Abstract for Presentation at the 2021 Connective Tissue Oncology Society Annual Meeting

author_avatar
NASDAQ Market News